Quality Improvement in Neurology: Multiple Sclerosis Quality Measurement Set 2020 Update

7Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Multiple sclerosis (MS) is a disabling immune-mediated disease of the CNS and considered one of the health conditions with the highest annual spending growth paid by both public and private insurance.1 Health care spending in the United States for MS was reported as $13.9 billion in 2016.1 The estimated cumulated (over 10 years) prevalence of MS among adults in the United States in 2010 was approximately 727,000.2 In 2017, that number was substantially higher, approximately 914,000.2,3 The prevalence is higher among women, with a female: male ratio of 2.8.2 Improving high-quality care for these patients can lead to improved outcomes, reduced spending, and better quality of life.

Cite

CITATION STYLE

APA

Rae-Grant, A., Amezcua, L., English, J., Garg, N., Giesser, B., Kelly, A. G., … Caller, T. (2021). Quality Improvement in Neurology: Multiple Sclerosis Quality Measurement Set 2020 Update. Neurology, 97(3), 134–141. https://doi.org/10.1212/WNL.0000000000012124

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free